Summary
UnitedHealth Group (UNH) demonstrated robust financial performance in the third quarter of 2023, with total revenues reaching $92.4 billion, a 14% increase year-over-year. This growth was driven by strong performance across both its UnitedHealthcare and Optum segments, with UnitedHealthcare revenues up 13% and Optum revenues up 22%. The company reported net earnings of $6.04 billion, or $6.24 per diluted share, reflecting continued operational strength and effective cost management. Key drivers for the quarter included serving a larger member base across Medicare Advantage and Medicaid, alongside growth in Optum Health, Insight, and Rx. Despite increased medical costs driven by higher care activity, particularly in outpatient procedures for seniors, the company maintained its medical care ratio at 82.3% and demonstrated strong operational earnings growth. The company also reported significant operating cash flow of $34.3 billion for the nine months ended September 30, 2023, underscoring its financial stability and ability to fund its growth initiatives, including approximately $5 billion in pending acquisitions.
Financial Highlights
54 data points| Revenue | $92.36B |
| Cost of Revenue | $9.42B |
| Gross Profit | $82.94B |
| SG&A Expenses | $13.86B |
| Operating Expenses | $83.83B |
| Operating Income | $8.53B |
| Interest Expense | $834.00M |
| Net Income | $5.84B |
| EPS (Basic) | $6.31 |
| EPS (Diluted) | $6.24 |
| Shares Outstanding (Basic) | 926.00M |
| Shares Outstanding (Diluted) | 936.00M |
Key Highlights
- 1Total revenues for Q3 2023 surged to $92.4 billion, a 14% increase from the prior year, driven by strong performance in both UnitedHealthcare and Optum segments.
- 2UnitedHealthcare segment revenues grew by 13% to $69.9 billion, serving 1.5 million more people year-over-year, with notable growth in Medicare Advantage and Commercial offerings.
- 3Optum segment revenues increased by 22% to $56.7 billion, showcasing robust growth across Optum Health, Insight, and Rx divisions.
- 4Net earnings attributable to common shareholders rose to $5.84 billion ($6.24 per diluted share) in Q3 2023, up from $5.26 billion ($5.55 per diluted share) in Q3 2022.
- 5Operating cash flow for the first nine months of 2023 reached $34.3 billion, indicating strong operational cash generation.
- 6The company continues to invest in growth, with $8.4 billion deployed in business combinations during the nine months ended September 30, 2023, and approximately $5 billion in pending acquisitions.
- 7UnitedHealth Group increased its quarterly cash dividend by 14% to an annual rate of $7.52 per share, signaling confidence in future performance and commitment to shareholder returns.